Completed Clinical Trials

A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma

By April 24, 2017 No Comments

Condition

Mesothelioma

Estimated Enrollment: 240

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: 5362|H3E-MC-JMEW

Study First Received: September 12, 2005

Last Updated: January 24, 2007

Estimated Primary Completion Date: null

 

Primary Outcome Measures:

The primary objective of this study is to compare the overall survival following treatment with Pemetrexed plus best supportive care versus best supportive care alone|To characterize and compare the toxicities of Pemetrexed/best supportive care and best supportive care alone in this patient population;to determine the objective-tumor response rate|to compare time to event efficacy variables of both arms including:duration of response,time to objective tumor response,time to treatment failure,time to documented disease progression,progression-free survival|to compare changes in the average symptom burden index between the Pemetrexed/best supportive care and best supportive care arms

Sponsors and Collaborators:

Eli Lilly and Company

Website Link: https://ClinicalTrials.gov/show/NCT00190762

Leave a Reply

Call Now